Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant

We want to thank N. Voermans et al. [1] for their critical comments to our publication [2].

Source: Neuromuscular Disorders - November 21, 2023 Category: Neurology Authors: S. Herdewyn, J. De Bleecker, L. Janssens, S. Symoens, M. Milazzo, J. De Puydt Tags: Letter to the editor Source Type: research